Age-independent, gray matter-localized, brain-enhanced oxidative stress in male fischer 344 rats: Brain levels of F2-isoprostanes and F4-neuroprostanes

Free Radical Biology and Medicine

Volumn 34, Issue 12, 2003, Pages 1631-1635

  Youssef, Jihan A ^a   Birnbaum, Linda S ^b   Swift, Larry L ^c   Morrow, Jason D ^c   Badr, Mostafa Z ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Aging; Brain oxidative stress; Free radicals; Gray matter; Isoprostanes; Neurodegenerative diseases; Neuroprostanes; White matter

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ISOPROSTANE DERIVATIVE; PROSTANOID;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN LEVEL; CONTROLLED STUDY; DATA ANALYSIS; GRAY MATTER; MALE; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; WHITE MATTER;

ANIMALIA;

EID: 0037683660     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00215-6     Document Type: Article

References (20)

1. Sawada M., Carlson J.C. Changes in superoxide radical and lipid peroxide formation in the brain, heart, and liver during the lifetime of the rat. Mech. Ageing Dev. 41:1987;125-137.
2. Dei R., Takeda A., Niwa H., Li M., Nakagomi Y., Watanabe T., Washimi Y., Yasuda Y., Horie K., Miyata T., Sobue G. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzeheimer's disease. Acta Neuropathol. 104:2002;113-122.
3. Dogru-Abbasoglu S., Tamer-Toptani S., Ugurnal B., Kocak-Tober N., Aykac-Toker G., Uysal M. Lipid peroxidation and antioxidant enzymes in livers and brains of aged rats. Mech. Ageing Dev. 98:1997;177-180.
4. Montine T., Neely D., Quinn J., Beal F., Markesbery W., Roberts L.J. II, Morrow J. Lipid peroxidation in aging brain and Alzeheimer's disease. Free Radic. Biol. Med. 33:2002;620-626.
5. Morrow J., Roberts L.J. II. The isoprostanes current knowledge and directions for future research . Biochem. Pharmacol. 51:1996;1-9.
6. Roberts L.J. II, Morrow J. Products of the isoprostane pathway unique bioactive compounds and markers of lipid peroxidation . Cell. Mol. Life Sci. 59:2002;808-820.
7. 2-isoprostane) metabolite in human urine and plasma. J. Biol. Chem. 268:1993;4161-4169.
8. 2-isoprostanes produced by noncyclooxygenase free radical-catalyzed mechanism . Methods Enzymol. 233:1994;163-174.
9. 2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA. 89:1992;10721-10725.
10. Reich E., Markesbery W., Roberts L.J. II, Swift L., Morrow J., Montine T. Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzeheimer's disease. Am. J. Pathol. 158:2001;293-297.
11. Skinner E.R., Watt C., Besson J.A.O., Best P.V. Differences in the fatty acid composition of the gray and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. Brain. 116:1993;717-726.
12. Morrow J.D., Roberts L.J. II. Quantification of noncyclooxygenase-derived prostanoids as a marker of oxidation stress. Free Radic. Biol. Med. 10:1991;195-200.
13. Roberts L.J. II, Montine T.J., Makesbery W.R., Tapper A.R., Hardy P., Chemtob S., Dettbarn W., Morrow J.D. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273:1998;13605-13612.
14. Morrison W.R., Smith L.M. Preparation of fatty acid methyl esters and dimethyl acetals with boron fluoride methanol. J. Lipid Res. 5:1964;600-608.
15. Halliwell B., Gutteridge J. Role of free radicals and catalytic metal ions in human disease an overview . Methods Enzymol. 186:1990;1-85.
16. Southorn P., Powis G. Free radicals in medicine. II. Involvement in human disease. Mayo Clinic Proc. 63:1988;390-408.
17. Roberts L.J. II, Morrow J.D. The generation and actions of isoprostanes. Biochim. Biophys. Acta. 1345:1997;121-135.
18. Morrow J.D., Roberts L.J. II. The isoprostanes unique bioactive products of lipid peroxidation . Prog. Lipid Res. 36:1997;1-21.
19. 4-neuroprostanes are not increased in Alzeheimer's disease. Ann. Neurol. 52:2002;175-179.
20. 2-isoprostane. Biochem. Biophys. Res. Commun. 195:1993;507-515.